E-LIB Suche - Ergebnisse für: Coakley, E

1

290 Documenting medication-related needs of older persons a..:

Fitzgerald, R ; Cahill, M ; Cronin, L...
Age and Ageing. 52 (2023) Supplement_3 - p. , 2023

Link: https://doi.org/10.1093/..

2

292 Frailty at the front door team compliance with the 4Ms ..:

Fitzgerald, R ; Coakley, E ; Condon, F...
Age and Ageing. 52 (2023) Supplement_3 - p. , 2023

Link: https://doi.org/10.1093/..

3

246 Feasibility of a delirium intervention pathway by a fra..:

Fitzgerald, R ; Mupada, B M ; Leonard, A...
Age and Ageing. 52 (2023) Supplement_3 - p. , 2023

Link: https://doi.org/10.1093/..

4

326 USE OF A PHARMACY PRIORITISATION TOOLKIT IN FRAIL OLDER..:

Kennedy, E ; Mulvihill, M ; Cronin, L...
Age and Ageing. 51 (2022) Supplement_3 - p. , 2022

Link: https://doi.org/10.1093/..

5

Incorporation of a nanotechnology-based product in cementit..:

Eyo, Eyo U. ; Abbey, Samuel J. ; Ngambi, Samson..
Engineering Science and Technology, an International Journal. 24 (2021) 2 - p. 436-448 , 2021

Link: https://doi.org/10.1016/..

6

RO7049389, a core protein allosteric modulator, demonstrate..:

Gane, E. ; Liu, A. ; Yuen, M.-F....
Journal of Hepatology. 68 (2018) - p. S101 , 2018

Link: https://doi.org/10.1016/..

7

RO7020531, a novel prodrug of a toll-like receptor 7 agonis..:

Gane, E. ; Folitar, I. ; Schwabe, C....
Journal of Hepatology. 68 (2018) - p. S514-S515 , 2018

Link: https://doi.org/10.1016/..

8

P0873 : Ombitasvir/paritaprevir/ritonavir and dasabuvir wit..:

Liu, Y. ; Larsen, L. ; Zeuzem, S....
Journal of Hepatology. 62 (2015) - p. S668 , 2015

Link: https://doi.org/10.1016/..

9

Serum miR‐122 may serve as a biomarker for response to dire..:

Waring, J. F. ; Dumas, E. O. ; Abel, S....
Journal of Viral Hepatitis. 23 (2015) 2 - p. 96-104 , 2015

Link: https://doi.org/10.1111/..

10

P0908 : Adherence to ombitasvir/paritaprevir/r, dasabuvir, ..:

Hassanein, T. ; Roberts, S. ; Shafran, S.D....
Journal of Hepatology. 62 (2015) - p. S685 , 2015

Link: https://doi.org/10.1016/..

11

LP39 : Implications of baseline HCVRNA level and intrapatie..:

Brown, R.S. ; Puoti, M. ; Cooper, C....
Journal of Hepatology. 62 (2015) - p. S283 , 2015

Link: https://doi.org/10.1016/..

12

Pharmacokinetics and Dose Recommendations for Cyclosporine ..:

Badri, P. ; Dutta, S. ; Coakley, E....
American Journal of Transplantation. 15 (2015) 5 - p. 1313-1322 , 2015

Link: https://doi.org/10.1111/..

13

P783 SERUM miR-122 MAY SERVE AS A BIOMARKER FOR RESPONSE TO..:

Waring, J.F. ; Dumas, E. ; Coakley, E....
Journal of Hepatology. 60 (2014) 1 - p. S331 , 2014

Link: https://doi.org/10.1016/..

14

O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFE..:

Feld, J.J. ; Kowdley, K.V. ; Coakley, E....
Journal of Hepatology. 60 (2014) 1 - p. S25 , 2014

Link: https://doi.org/10.1016/..

15

O114 RESULTS OF THE PHASE 2 STUDY M12-999: INTERFERON-FREE ..:

Kwo, P. ; Mantry, P. ; Coakley, E....
Journal of Hepatology. 60 (2014) 1 - p. S47 , 2014

Link: https://doi.org/10.1016/..